On June 19, 2023, under the leadership of Chairman Dr. Chen Guicai,ZHEJIANG ESIGMA BIOTECHNOLOGY CO.,LTD. participated in the 21st CPhI China 2023. This exhibition brings together the cutting-edge information of the pharmaceutical market, presenting a comprehensive one-stop pharmaceutical industry trade platform for more than 3,000 exhibitors and more than 50,000 professional buyers from more than 120 countries.

ESIGMA participated in the event. The open and simple layout gives a refreshing visual enjoyment. The 3-day exhibition had an endless stream of customers, new and old customers from various countries and regions gathered together, and the scene was lively.

This CHPI exhibition, met a lot of new customers, but also for many old customers to provide professional technical advice, and strive to do better service. Today, the reputation of ESIGMA has been far overseas, and the main products: growth promoters and anti-coccidia products have also been famous. This is a kind of encouragement to ESIGMA company, but also a spur. Only more sincere service for customers, in order to lay a more solid foundation for ESIGMA.